UNSPSC 51201823: Molgramostim

This classification denotes a therapeutic granulocyte-macrophage colony-stimulating factor with the molecular formula C639H1007N171O196S8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B321AL142J, more generally known as molgramostim. European Medicines Agency schedules molgramostim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09040MIG. The term MOLGRAMOSTIM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, no. 3 1991, list 31.

UNSPSC 51201823 Molgramostim is a Commodity code covering immunobiological products; recent state and local solicitation activity under this code shows little alignment with the nominal product scope. The single recent posting—a sole source procurement notice from the Mississippi State Department of Health for Yellow Fever Vaccine from Sanofi Pasteur—addresses a different vaccine product outside the molgramostim category. State and local governments soliciting under this code seek immunobiological pharmaceuticals for public health programs, though the recent record does not support a pattern of molgramostim-specific procurement at this time.

The Mississippi State Department of Health posted the Yellow Fever Vaccine notice on July 13, 2026, with objections due August 3, 2026, under sole source classification; the notice invites written challenge to the exclusivity claim and reserves the right to conduct competitive procurement if alternative sources substantiate availability. The source does not disclose quantity, contract term, or estimated value. Geographic activity and issuing-body patterns cannot be characterized from a single posting, and no representative molgramostim-specific opportunities are present in the recent record.